MDRX official logo MDRX
MDRX 1-star rating from Upturn Advisory
Veradigm Inc. (MDRX) company logo

Veradigm Inc. (MDRX)

Veradigm Inc. (MDRX) 1-star rating from Upturn Advisory
$4.31
Last Close (24-hour delay)
upturn advisory logo
PASS
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock price based on last close icon Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

02/20/2026: MDRX (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

Upturn 1 star rating for performance

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

1 star rating from financial analysts

3 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $5.83

1 Year Target Price $5.83

Analysts Price Target For last 52 week
$5.83 Target price
52w Low $3
Current$4.31
52w High $6
Advertisement

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 535.79M USD
Price to earnings Ratio -
1Y Target Price 5.83
Price to earnings Ratio -
1Y Target Price 5.83
Volume (30-day avg) 3
Beta 0.53
52 Weeks Range 3.00 - 6.00
Updated Date 11/15/2025
52 Weeks Range 3.00 - 6.00
Updated Date 11/15/2025
Dividends yield (FY) -
Basic EPS (TTM) -0.18

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Advertisement

Earnings Date

Report Date 2026-02-27
When -
Estimate 0.07
Actual -

Profitability

Profit Margin -14.7%
Operating Margin (TTM) 16.59%

Management Effectiveness

Return on Assets (TTM) -0.62%
Return on Equity (TTM) -1.69%

Valuation

Trailing PE -
Forward PE 15.17
Enterprise Value 241120000
Price to Sales(TTM) 0.88
Enterprise Value 241120000
Price to Sales(TTM) 0.88
Enterprise Value to Revenue 0.41
Enterprise Value to EBITDA 4.13
Shares Outstanding 108900000
Shares Floating 81497489
Shares Outstanding 108900000
Shares Floating 81497489
Percent Insiders 4.36
Percent Institutions 40.99

Icon representing Upturn AI-generated SWOT analysis summary Upturn AI SWOT

Veradigm Inc.

Veradigm Inc.(MDRX) company logo displayed in Upturn AI summary

Company Overview

Company history and background logo History and Background

Veradigm Inc. (formerly Allscripts Healthcare Solutions, Inc.) has a long history in the health IT sector. It was founded in 1986. The company has undergone significant transformations, including mergers, acquisitions, and rebranding. A major milestone was the acquisition of various health IT assets and the subsequent rebranding to Veradigm to reflect its focus on digital health and data analytics. Its evolution reflects the broader trends in healthcare technology, moving from electronic health records (EHR) to more integrated data solutions.

Company business area logo Core Business Areas

  • Veradigm EHR and Practice Management: Provides electronic health record (EHR) and practice management solutions to ambulatory physician practices, enabling clinical workflow, patient engagement, and revenue cycle management.
  • Veradigm Data Solutions: Offers a suite of data analytics, population health management, and patient engagement tools that leverage aggregated and de-identified health data to improve outcomes and reduce costs. This includes data aggregation, insights, and research services.
  • Veradigm Payment Solutions: Focuses on revenue cycle management services, helping healthcare providers optimize billing, coding, and claims processing to improve financial performance.

leadership logo Leadership and Structure

Veradigm Inc. is led by a management team with experience in healthcare technology and business operations. The organizational structure is typically segmented by its core business areas, with dedicated teams for product development, sales, marketing, and customer support within each segment. Specific leadership roles and their responsibilities can be found on the company's investor relations website.

Top Products and Market Share

Product Key Offerings logo Key Offerings

  • Veradigm EHR: A comprehensive electronic health record system designed for ambulatory physician practices. It supports clinical documentation, e-prescribing, order entry, and patient portals. Competitors include Epic Systems, Cerner (now Oracle Health), Athenahealth, and NextGen Healthcare. Market share is fragmented, but Veradigm is a significant player in the ambulatory EHR market.
  • Veradigm Data & Analytics Platform: This platform aggregates data from various sources, including EHRs, to provide insights for population health management, clinical research, and payer analytics. Key competitors include Optum, Health Catalyst, and IBM Watson Health (though some parts have been divested). Veradigm aims to differentiate through its extensive network and the breadth of data it can access.
  • Veradigm Patient Engagement Solutions: Includes patient portals, appointment scheduling tools, and secure messaging to enhance communication between patients and providers. Competitors include Zocdoc, Luma Health, and often integrated features within EHR systems from major players.

Market Dynamics

industry overview logo Industry Overview

The healthcare IT industry is characterized by rapid technological advancement, increasing regulatory scrutiny, and a growing demand for interoperability and data-driven insights. Key trends include the shift towards value-based care, the adoption of AI and machine learning, and the focus on patient experience and digital health. The industry is highly competitive with a mix of large established players and innovative startups.

Positioning

Veradigm positions itself as a key enabler of the modern digital healthcare ecosystem. Its competitive advantages lie in its extensive network of providers, its ability to aggregate and analyze diverse health data, and its integrated suite of solutions spanning EHR, data analytics, and payment solutions. The company aims to bridge the gap between clinical care, data utilization, and financial performance.

Total Addressable Market (TAM)

The TAM for health IT solutions is substantial and growing, encompassing EHRs, data analytics, population health management, patient engagement, and revenue cycle management. Estimates vary, but the global health IT market is projected to reach hundreds of billions of dollars in the coming years. Veradigm is positioned to capture a significant portion of this TAM by offering integrated solutions that address multiple facets of healthcare operations and data utilization.

Upturn SWOT Analysis

Strengths

  • Extensive network of healthcare providers and a large patient data repository.
  • Integrated suite of solutions covering EHR, data analytics, and revenue cycle management.
  • Focus on interoperability and data-driven insights.
  • Established relationships with payers and life sciences companies.

Weaknesses

  • Past financial performance and operational challenges.
  • Dependence on third-party partnerships for certain data access.
  • Intense competition from larger, more well-capitalized players.
  • Need for continuous innovation to keep pace with evolving technology.

Opportunities

  • Growing demand for real-world evidence (RWE) in drug development and clinical research.
  • Expansion into new markets and service offerings related to value-based care.
  • Leveraging AI and machine learning to enhance data analytics capabilities.
  • Strategic partnerships to expand reach and service offerings.

Threats

  • Increasing cybersecurity risks and data privacy regulations (e.g., HIPAA).
  • Changes in healthcare reimbursement policies and government regulations.
  • Rapid technological advancements by competitors.
  • Economic downturns impacting healthcare spending.

Competitors and Market Share

Key competitor logo Key Competitors

  • Epic Systems (EPIC)
  • Oracle Health (formerly Cerner) (ORCL)
  • Athenahealth (ATHENA)
  • NextGen Healthcare (NXGN)
  • Optum (part of UnitedHealth Group) (UNH)
  • Health Catalyst (HCAT)

Competitive Landscape

Veradigm faces intense competition from large, established EHR vendors and specialized data analytics firms. Its advantages lie in its integrated approach and its extensive network for data aggregation. However, it often competes with companies that have larger R&D budgets and more established brand recognition in specific market segments. Differentiation through specialized data offerings and unique partnerships is key.

Growth Trajectory and Initiatives

Historical Growth: Veradigm has experienced periods of growth driven by acquisitions and expansion of its product and service offerings. However, it has also faced challenges in integrating acquisitions and achieving consistent organic growth in certain segments. The company's growth trajectory has been marked by strategic realignments to focus on its core strengths in data and digital health.

Future Projections: Future growth projections for Veradigm are likely tied to the increasing demand for data analytics in healthcare, the adoption of value-based care models, and its ability to secure new contracts with providers, payers, and life sciences companies. Analyst consensus, if available, would provide specific revenue and earnings growth estimates. Key growth drivers are expected to be its data solutions and participation in value-based care initiatives.

Recent Initiatives: Recent initiatives have focused on enhancing its data analytics platform, expanding its capabilities in real-world evidence generation, and strengthening its partnerships within the healthcare ecosystem. This includes efforts to improve data interoperability and provide actionable insights to stakeholders.

Summary

Veradigm Inc. operates in the dynamic health IT sector, with core strengths in EHR, data analytics, and revenue cycle management, supported by an extensive provider network. The company's ability to aggregate and analyze real-world health data presents significant opportunities, particularly in RWE for life sciences and value-based care initiatives. However, Veradigm faces stiff competition from larger players and must navigate evolving regulatory landscapes and cybersecurity threats. Continued investment in innovation and strategic partnerships are crucial for its future growth and competitive positioning.

Similar Stocks

Sources and Disclaimers

Data Sources:

  • Company Investor Relations Filings (SEC: 10-K, 10-Q)
  • Industry Research Reports
  • Financial News Outlets
  • Company Website

Disclaimers:

This analysis is based on publicly available information and is for informational purposes only. It does not constitute investment advice. Financial data and market share figures are estimates and subject to change. Users should conduct their own due diligence before making any investment decisions.

Information icon for Upturn AI Summarization accuracy disclaimer AI Summarization is directionally correct and might not be accurate.

Information icon for Upturn AI Summarization data freshness disclaimer Summarized information shown could be a few years old and not current.

Information icon warning about Upturn AI Fundamental Rating based on potentially old data Fundamental Rating based on AI could be based on old data.

Information icon warning about potential inaccuracies or hallucinations in Upturn AI-generated summaries AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Veradigm Inc.

Exchange NASDAQ
Headquaters Chicago, IL, United States
IPO Launch date 1999-07-26
CEO -
Sector Healthcare
Industry Health Information Services
Full time employees 2450
Full time employees 2450

Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising practice management software, AI patient scheduling software, and electronic statements and payments, and payerpath clearinghouse; revenue cycle services and coding services; electronic health records solutions, which include eprescribe with EPCS, EHR software, veradigm EHR, and practice fusion EHR; and patient engagement platform. It also provides solutions to network partners, which comprise API connectivity solutions, such as veradigm connect, veradigm app expo, and diagnostic ordering and resulting network; life sciences, health plans and payers, and providers; and veradigm eprescribe enterprise. In addition, the company offers risk adjustment solutions, such as health equity analytics, risk adjustment analytics, risk mitigator, comprehensive submissions, and utilization analytics; quality analytics, risk adjustment, and quality management; data exchange and coding solutions, including echart courier, echart coder, and echart integration and analytics; clinical data registries for physicians and veradigm payer insights; provider engagement solutions; care gap alerting, gap closure services, and veradigm payerpath solutions. Further, it provides real world data solutions, such as NLP-enriched EHR data solutions, and clinical data registries; real world evidence and real-world evidence analytics platform; and digital health media solutions. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.